TYSON KINNICK: Open Payments
NPI 1881019925 · ALAMOSA, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$209 in 9 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $75 · 2025 $209
Food & beverage: $177Education: $32
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $53 |
| Corcept Therapeutics | 2 | $47 |
| Edwards Lifesciences Corporation | 1 | $27 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $22 |
| Amgen Inc. | 1 | $14 |
Products named: Ozempic, Korlym, SAPIEN 3 Ultra RESILIA, CAPLYTA, AUSTEDO XR, JOURNAVX, OTEZLA.
Industry payments across CO — which companies pay providers there.
